Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-3831
Fax+1 415-502-4372
Dr. Chesler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCSF Benioff Children’s Hospital OaklandFellowship, Pediatric Hematology/Oncology, 2000 - 2003
University of California (San Francisco)Residency, Pediatrics, 1997 - 2000
Northwestern University The Feinberg School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2027
Publications & Presentations
PubMed
- 18 citationsCirculating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.Reda Stankunaite, Sally L George, Lewis Gallagher, Sabri Jamal, Ridwan Shaikh
European Journal of Cancer. 2022-02-01 - 9 citationsMYC regulates metabolism through vesicular transfer of glycolytic kinases.Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, Alessandra Eva, Giuliana Cangemi
Open Biology. 2021-12-01 - 3 citationsThe biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme.Zuzanna Urban-Wójciuk, Amy Graham, Karen Barker, Colin Kwok, Yordan Sbirkov
Cancer Gene Therapy. 2021-09-14
Press Mentions
- Three New Research Teams Aim to Improve Therapies for Difficult-to-Treat Pediatric CancersOctober 19th, 2020
Children and Young People with Cancer Who Have Relapsed Can Get Rapid Access to New Treatments, Thanks to New Cancer Research UK TrialSeptember 4th, 2020
Dr. Elliot Chesler, Who Created One of Top VA Cardiology Units in Country, Dies at 87July 17th, 2019- Join now to see all
Grant Support
- PROTECT - Develop therapeutics to target oncogenic drivers of solid tumours in childrenTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL2024–2025
- Role Of MYCN Inhibition In NBL Tumor ProgressionNational Institute Of Neurological Disorders And Stroke2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
